Home > Journals > Medicine > Hépato-Gastro > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Hépato-Gastro
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Acute renal failure in patients with cirrhosis


Hépato-Gastro. Volume 15, Number 4, 267-73, Juillet-Août 2008, Mini-revue

Résumé   Article gratuit  

Author(s) : Marika Rudler, Dominique Thabut

Summary : Acute renal failure (ARF) is a severe complication of cirrhosis, with poor prognosis and various causes. Most ARF are related to prerenal failure, due either to true hypovolemia, or more rarely to hepatorenal syndrome, with or without ongoing infection. Nephrotoxic drugs or contrast medium can be responsible for renal hypoperfusion or for acute tubular necrosis. Initial evaluation must include blood and urinary tests and renal ultrasonography. Renal biopsy is generally not necessary. Main prognostic factors are the severity of cirrhosis and the presence of a systemic inflammatory response syndrome, with or without ongoing infection. Treatment depends on the aetiology of ARF. Nephrotoxic drugs should always be stopped. Liver transplantation is the optimal treatment of hepatorenal syndrome. The recommended symptomatic treatment is the association of terlipressin and albumin, which should be continued except when creatininemia does not decrease. In case of acute tubular necrosis, symptomatic treatment is needed, and renal-replacement therapy should be discussed. Prevention of ARF is essential. In patients with spontaneous bacterial peritonitis, intravenous albumin perfusion, in addition to antibiotics improves mortality as compared to antibiotics alone. Contrast medium-induced renal failure may be prevented with oral acetylcystein therapy. Nephrotoxic drugs like aminoglycosides and non-steroidal antiinflammatory drugs should always be avoided in cirrhotic patients.

Keywords : cirrhosis, renal failure, inflammation, nephrotoxic agent

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]